PetMed Express, Inc.
PETS
$2.74
-$0.01-0.36%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -17.19% | -13.33% | -6.71% | -0.42% | 6.77% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -17.19% | -13.33% | -6.71% | -0.42% | 6.77% |
| Cost of Revenue | -16.63% | -16.86% | -10.44% | -4.04% | 1.87% |
| Gross Profit | -18.44% | -4.32% | 3.00% | 8.99% | 19.61% |
| SG&A Expenses | -17.11% | -14.17% | -0.86% | 9.27% | 39.98% |
| Depreciation & Amortization | -0.24% | 11.45% | 32.26% | 58.78% | 98.98% |
| Other Operating Expenses | -8.27% | -416.28% | -416.28% | -185.74% | -185.74% |
| Total Operating Expenses | -16.46% | -16.00% | -7.63% | -0.49% | 11.45% |
| Operating Income | -19.78% | 199.90% | 218.29% | 13.88% | -195.55% |
| Income Before Tax | 90.64% | 181.84% | -619.15% | -105.49% | -188.51% |
| Income Tax Expenses | 377.25% | 380.86% | -49.63% | 73.24% | -47.04% |
| Earnings from Continuing Operations | 15.98% | 113.40% | -13.43% | -353.60% | -254.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.98% | 113.40% | -13.43% | -353.60% | -254.28% |
| EBIT | -19.78% | 199.90% | 218.29% | 13.88% | -195.55% |
| EBITDA | -21.98% | 363.90% | 79.52% | 31.48% | -94.50% |
| EPS Basic | 17.19% | 112.40% | -16.51% | -350.99% | -252.70% |
| Normalized Basic EPS | -53.27% | 387.81% | 147.16% | -24.30% | -147.61% |
| EPS Diluted | 18.71% | 104.41% | -16.67% | -401.30% | -260.60% |
| Normalized Diluted EPS | -56.09% | 375.97% | 140.12% | -27.89% | -148.16% |
| Average Basic Shares Outstanding | 0.98% | 0.88% | 0.78% | 0.67% | 0.60% |
| Average Diluted Shares Outstanding | 1.43% | 1.32% | 1.22% | 1.57% | 0.87% |
| Dividend Per Share | -- | -100.00% | -100.00% | -75.00% | -50.00% |
| Payout Ratio | 0.98% | 1.08% | 0.99% | -1.10% | -1.33% |